Korean J Intern Med.
1998 Feb;13(1):33-40.
Comparison of plasma amino acid concentrations in end-stage renal disease
patients on hemodialysis and peritoneal dialysis
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang Hospital, Chunan City, Korea.
- 2Department of Anesthesia, Dankook University Hospital, Chunan City, Korea.
Abstract
OBJECTIVES
Recent reports have suggested that patients treated by CAPD have a
relatively increased risk of death compared to patients undergoing HD, although
the cause of this discrepancy is poorly understood. Protein malnutrition is an
important risk factor in ESRD. Also, amino acid concentrations, for which the
physiological function differs from that of protein, may be an independent risk
factor in ESRD. There is no doubt concerning the prevalence of low amino acid
levels in both HD and CAPD patients. But the difference in plasma amino acid
levels between these two groups has not been well defined. The purpose of this
study is to compare plasma amino acid levels between patients with ESRD on HD
and CAPD. METHODS: A cross sectional study of overnight fasting plasma amino
acid concentrations was performed on 12 CAPD and 45 HD patients with ESRD,
matched by age, sex and body mass index. The levels of individual plasma amino
acid and TAA, EAA, NEAA and BCAA were compared for the HD and CAPD groups. In
order to measure losses during HD and CAPD, amino acid and protein
concentrations were measured from 10 dialysates obtained from 10 HD patients and
12 peritoneal dialysis solutions from 12 CAPD patients. RESULTS: All of the
measured amino acid concentrations were found to be lower in the CAPD group
compared to the HD group. Furthermore, the levels of TAA (2017.3 +/- 781.1 vs.
903.3 +/- 316.1 mumole/L), EAA(1201.8 +/- 492.6 vs. 567.6 +/- 223.2 mumole/L),
NEAA(815.5 +/- 308.6 vs. 335.7 +/- 100.2 mumole/L); and BCAA (315.0 +/- 146.0
vs. 145.2 +/- 65.0 mumole/L), were all lower in the CAPD group than in the HD
group. The protein loss was 2.0 +/- 0.2 g/L in the peritoneal dialysate but was
not detectable in the hemodialysates. TAA loss over a one week period was about
61.8 +/- 13.0mmole for the HD group and 38.0 +/- 13.0 mmole for the CAPD group.
CONCLUSIONS
Our results show that amino acid concentrations are lower in ESRD
patients on CAPD than on HD. It seems likely that protein loss in the peritoneal
dialysate is a contributing factor to lowered plasma amino acid concentrations
in ESRD patients on CAPD than on HD. We believe that the lowered amino acid
concentrations observed in CAPD patients may worsen the clinical outcome
compared to HD patients.